The Column Group
Overview
The Column Group is a leading venture capital firm dedicated to creating the next generation of biotechnology companies
Investment Focus
- Innovative drug discovery companies
- Focus on unmet medical needs
- Pre-IPO and public companies
Portfolio Companies
Reach The Column Group directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about The Column Group
What sectors does The Column Group invest in?
The Column Group invests in Healthcare, Life Sciences, Pharmaceuticals, Medical Devices, Diagnostics and Biotechnology, and is based in Usa. The Column Group is listed as a vc in the ConnectSafely investor database.
What stage does The Column Group invest at?
The Column Group backs companies at Early Stage, Growth, Late Stage and Pre-IPO, writing cheques of 10M - 50M.
Which regions does The Column Group invest in?
The Column Group invests across United States, Europe and China.
Who are the partners at The Column Group?
Team members listed for The Column Group include PETER Svennilson (Managing Partner and Founder) and Carla Daniel (Partner & Chief People Officer).
What companies has The Column Group invested in?
The Column Group's portfolio includes Neurona Therapeutics, Synthekine, RAPT Therapeutics, ORIC Pharmaceuticals, Remix Therapeutics and Accent Therapeutics.
How do I contact The Column Group?
The Column Group's contact details — including phone — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
